Home Longitudinal changes in serum paraoxonase-1 activity throughout normal pregnancy
Article
Licensed
Unlicensed Requires Authentication

Longitudinal changes in serum paraoxonase-1 activity throughout normal pregnancy

  • Natàlia Ferré , Jordi Camps , Joan Fernández-Ballart , Victoria Arija , Michelle M. Murphy , Judit Marsillach and Jorge Joven
Published/Copyright: September 21, 2011

Abstract

The aim of this study was to investigate the longitudinal changes in serum paraoxonase-1 (PON1) activity from preconception throughout normal pregnancy and their relationships with maternal dietary vitamin C and E intake. The study was performed in 35 women (studied at preconception, at 8, 20 and 32weeks of pregnancy, and at labour). PON1 activity decreased significantly from 145.8 (109.8–198.8) U/L at preconception to 111.1 (85.3–179.9) U/L (p<0.01) at 32weeks and 100.4 (54.7–171.4) U/L (p<0.001) at labour. There was a direct association between vitamin C intake and PON1 at week 32 (p=0.018). We conclude that adequate vitamin C intake in pregnant women may merit consideration, since vitamin C supplementation has proved beneficial in the prevention of preeclampsia in women at increased risk of this condition.

Clin Chem Lab Med 2006;44:880–2.


Corresponding author: Dr. Jordi Camps, Centre de Recerca Biomèdica, Hospital Universitari de Sant Joan, C/. Sant Joan s/n, 43201 Reus, Catalunya, Spain Phone: +34-977-308128, Fax: +34-977-312569,

References

1. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. Br Med J 2000; 323:1213–7.10.1136/bmj.323.7323.1213Search in Google Scholar

2. Henriksen T. The role of lipid oxidation and oxidative lipid derivatives in the development of preeclampsia. Semin Perinatol 2000; 24:29–32.10.1016/S0146-0005(00)80051-8Search in Google Scholar

3. Toescu V, Nuttall SL, Martin U, Kendall MJ, Dunne F. Oxidative stress and normal pregnancy. Clin Endocrinol 2002; 57:609–13.10.1046/j.1365-2265.2002.01638.xSearch in Google Scholar

4. Toescu V, Nuttall SL, Martin U, Nightingale P, Kendall MJ, Brydon P, et al. Changes in plasma lipids and markers of oxidative stress in normal pregnancy and pregnancies complicated by diabetes. Clin Sci 2004; 106:93–8.10.1042/CS20030175Search in Google Scholar

5. Armstrong VW, Wieland E, Diedrich F, Renner A, Rath W, Kreuzer H, et al. Serum antibodies to oxidised low-density lipoprotein in pre-eclampsia and coronary hearth disease. Lancet 1994; 343:1570.10.1016/S0140-6736(94)92971-8Search in Google Scholar

6. De Vriese SR, Dhont M, Christophe AB. Oxidative stability of low density lipoproteins and vitamin E levels increase in material blood during normal pregnancy. Lipids 2001; 36:361–6.10.1007/s11745-001-0728-2Search in Google Scholar

7. Sarandöl E, Dirican M, Serdar Z. Oxidizability of apolipoprotein B-containing lipoproteins, levels of lipid peroxidation products and antioxidants in normal pregnancy. Arch Gynecol Obstet 2004; 270:157–60.10.1007/s00404-003-0524-7Search in Google Scholar

8. Mackness B, Durrington PN, Mackness MI. Polymorphisms of paraoxonase genes and low-density lipoprotein lipid peroxidation. Lancet 1999; 353:468–9.10.1016/S0140-6736(98)05105-8Search in Google Scholar

9. Jarvik GP, Tsai NT, McKinstry LA, Wani R, Brophy VH, Richter RJ, et al. Vitamin C and E intake is associated with increased paraoxonase activity. Arterioscler Thromb Vasc Biol 2002; 22:1329–33.10.1161/01.ATV.0000027101.40323.3ASearch in Google Scholar

10. Ferré N, Camps J, Fernández-Ballart J, Arija V, Murphy MM, Ceruelo S, et al. Regulation of serum paraoxonase activity by genetic, nutritional, and lifestyle factors in the general population. Clin Chem 2003; 49:1491–7.10.1373/49.9.1491Search in Google Scholar PubMed

11. Kleemola P, Freese R, Hauhiainen M, Pahlman R, Alfthan G, Mutanen M. Dietary determinants of serum paraoxonase activity in healthy humans. Atherosclerosis 2002; 160:425–32.10.1016/S0021-9150(01)00594-9Search in Google Scholar

12. Murphy MM, Scott JM, McPartlin JM, Fernandez-Ballart JD. The pregnancy-related decrease in fasting plasma homocysteine is not explained by folic acid supplementation, hemodilution, or a decrease in albumin in a longitudinal study. Am J Clin Nutr 2002; 76:614–9.10.1093/ajcn/76.3.614Search in Google Scholar

13. Thompson FE, Byers T. Dietary assessment resource manual. J Nutr 1994; 124(11 Suppl):2245–317.Search in Google Scholar

14. Berkowitz GS, Wetmur JG, Birman-Deych E, Obel J, Lapinski RH, Godbold JH, et al. In utero pesticide exposure, maternal paraoxonase activity, and head circumference. Environ Health Perspect 2004; 112:388–91.10.1289/ehp.6414Search in Google Scholar

15. Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier CL, et al. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Rad Biol Med 1999; 26:892–904.10.1016/S0891-5849(98)00272-XSearch in Google Scholar

16. Roy AC, Loke DF, Saha N, Viegas OA, Tay JS, Ratnam SS. Interrelationships of serum paraoxonase, serum lipids and apolipoproteins in normal pregnancy. A longitudinal study. Gynecol Obstet Invest 1994; 38:10–3.10.1159/000292435Search in Google Scholar

17. Carpintero A, Sánchez-Martín MM, Cabezas-Delamare MJ, Cabezas JA. Variation in serum arylesterase, β-glucoronidase, cathepsin L and plasminogen activators during pregnancy. Clin Chim Acta 1996; 255:153–64.10.1016/0009-8981(96)06403-0Search in Google Scholar

Received: 2006-2-16
Accepted: 2006-4-8
Published Online: 2011-9-21
Published in Print: 2006-7-1

©2006 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Flow-cytometric immunophenotyping of normal and malignant lymphocytes
  2. Recommendation to treat continuous variable errors like attribute errors
  3. Polymorphisms associated with apolipoprotein B levels in Greek patients with familial hypercholesterolemia
  4. Lack of association between α2B-adrenergic receptor polymorphism and risk of restenosis following coronary angioplasty and stent implantation – preliminary report
  5. Prognostic value of homocysteinemia in patients with congestive heart failure
  6. Comparability of indices for insulin resistance and insulin secretion determined during oral glucose tolerance tests
  7. Evaluation of clinical markers of atherosclerosis in young and elderly Japanese adults
  8. Hypoadiponectinemia is associated with symptomatic atherosclerotic peripheral arterial disease
  9. Cardiac troponin T and amino-terminal pro-natriuretic peptide concentrations in fetuses in the second trimester and in healthy neonates
  10. Autoantibody profiling of patients with autoimmune thyroid disease using a new multiplexed immunoassay method
  11. Fluorimetric determination of activity and isoenzyme composition of N-acetyl-β-D-hexosaminidase in seminal plasma of fertile men and infertile patients with secretory azoospermia
  12. Increased fructosamine in non-diabetic rheumatoid arthritis patients: role of lipid peroxides and glutathione
  13. Usefulness of whole blood aggregometry and its comparison with thromboxane generation assay in monitoring acetylsalicylic acid effectiveness – a multiparametric study in rats
  14. Elevated plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with dyskinesias
  15. Use of total patient data for indirect estimation of reference intervals for 40 clinical chemical analytes in Turkey
  16. Use of haemolysis index to estimate potassium concentration in in-vitro haemolysed serum samples
  17. Longitudinal changes in serum paraoxonase-1 activity throughout normal pregnancy
  18. Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT® analyzer
  19. Evaluation and quality assessment of glucose concentration measurement in blood by point-of-care testing devices
  20. Hypothesis on interferences in kinetic interaction of microparticles in solution (KIMS) technology
  21. Comparability of point-of-care whole-blood electrolyte and substrate testing using a Stat Profile Critical Care Xpress analyzer and standard laboratory methods
  22. Determination of the length of sedimentation reaction in blood using the TEST 1 system: comparison with the Sedimatic 100 method, turbidimetric fibrinogen levels, and the influence of M-proteins
  23. Transcriptions and ISO 15189
  24. Falsely elevated troponin I attributed to inadequate centrifugation using the Access® immunoassay analyzer
  25. Interference of sulfamethoxazole in Capillarys® electrophoresis
Downloaded on 18.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2006.156/html
Scroll to top button